![]() |
![]() |
| J Audiol Otol > Volume 30(4); 2026 > Article |
|
Author Contributions
Conceptualization: Han-Seul Na, Sung-Won Choi. Data curation: Han-Seul Na, Dong-Hoon Lee. Formal analysis: Han-Seul Na. Funding acquisition: Sung-Won Choi. Investigation: Dong-Hoon Lee. Methodology: Han-Seul Na, Sung-Won Choi. Project administration: Sung-Won Choi. Resources: Dong-Hoon Lee. Software: Han-Seul Na. Supervision: Sung-Won Choi. Validation: Han-Seul Na, Dong-Hoon Lee. Visualization: Han-Seul Na, Dong-Hoon Lee. Writing—original draft: Han-Seul Na. Writing—review & editing: Han-Seul Na, Sung-Won Choi. Approval of final manuscript: all authors.
Funding Statement
This research was supported by the Bio and Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MSIT) (No. RS-2023-00223764). This research was also supported by a clinical research grant from Pusan National University Hospital in 2026.
| Instrument | Target condition | No. of items | Scoring range | Diagnostic cutoff | Cronbach’s α | Test–retest reliability | Sensitivity/specificity | Validation status | Key reference |
|---|---|---|---|---|---|---|---|---|---|
| ETDQ-7 | Obstructive ETD | 7 | Likert 1-7 per item; total 7-49 | ≥14.5 (mean ≥2.1) | 0.71 | r=0.78 | Original: Sen 100%, Spe 100% vs. objective tests: Sen 45%-54%, AUC 0.631 | Multiple languages (German, Dutch, Spanish, Portuguese, Turkish, Korean, Filipino, Greek) | McCoul, et al. 2012 [11] |
| MCID >3.5 | |||||||||
| PHI-10 | Patulous ETD | 10 | 0-40 (4-grade: none 0-8, mild 10-16, moderate 18-24, severe 26-40) | ≥26 (severe handicap) | NR | NR | NR | Japanese; adapted from THI | Ikeda, et al. 2017 [29] |
| CETDA | All ETD subtypes | 10 | NR | NR | >0.9 | r=0.92 | Spe 33% (vs. other otological conditions) | English | Smith, et al. 2018 [23] |
| Failed to discriminate obstructive vs. patulous ETD | |||||||||
| VAS | Symptom-specific (e.g., ear stuffiness) | 1 | 0-10 or 0-100 mm | Variable | N/A | N/A | N/A | Generic; not disease-specific | Various |
Combined scoring systems integrating PROMs with objective test data (ETS-7, ETS-5, T-ETDQ) are presented in Table 2 and discussed in Sections 5.2. ETDQ-7, Eustachian Tube Dysfunction Questionnaire-7; PHI-10, Patulous Eustachian Tube Handicap Inventory-10; CETDA, Cambridge Eustachian Tube Dysfunction Assessment; VAS, Visual Analogue Scale; THI, Tinnitus Handicap Inventory; Sen, sensitivity; Spe, specificity; AUC, area under the receiver operating characteristic curve; MCID, minimal clinically important difference; NR, not reported.
| Test | TM requirement | Detection/opening rate | Sensitivity | Specificity | Repeatability | Equipment requirements | Clinical availability |
|---|---|---|---|---|---|---|---|
| Tympanometry-Based Tests | |||||||
| Standard tympanometry | Intact | N/A (static test; does not detect ET opening events)* | Low for ETD (29%-40%) [53] | High for MEE | Good (standard clinical tool) | Standard tympanometer (226 Hz probe) | Widely available |
| Inflation-deflation test | Perforated | PEq5 cutoff <60% [16] | 75% (overpressure) [36] | 65% (overpressure) [36] | NR | Standard tympanometer+pressure delivery system | Moderate |
| 95% (combined parameters) [36] | 83% (combined parameters) [36] | ||||||
| Nine-step test (Bluestone’s test) | Intact only | 93%-94% in healthy ears [45] | 73.7% (MPD ≤13 daPa) [40] | 90.0% [40] | NR; conflicting normative cutoffs across populations (≤13 vs. ≤4 daPa) | Standard tympanometer with ETF module (e.g., GSI TympStar Pro) | Widely available |
| 91% (baro-challenge) [9] | 100% (baro-challenge) [9] | ||||||
| Pressure chamber test | Intact | PEq5 cutoff <60%; reference standard for baro-challenge ETD | NR (reference standard) | NR (reference standard) | Good (standardized pressure gradients) | Sealed hypo-hyperbaric chamber; trained personnel | Research centers only |
| Continuous impedance monitoring | Intact | 88% (Valsalva) [45] | Not formally reported | Not formally reported | NR | Impedance audiometer (226 Hz, 85 dB SPL); sealed EAC probe | Moderate (useful for PET detection) |
| 92.7% (Valsalva) [44] | |||||||
| 45%-53% (swallowing) [45] | |||||||
| Sonotubometry | |||||||
| Sonotubometry (standard) | Both | 94% (dry swallow) [45] | 63% [53] | 79% [53] | 98.1% detection with PSEQ [57] | Sound generator (nasal)+microphone (EAC)+signal processor | Limited (specialized centers) |
| 90.9% [44] | 74.2% [47] | 65.6% [47] | |||||
| 92.5% [54] | 73.2% [54] | ||||||
| Sonotubometry (Ohta method) | Both | Δ15 dB between upright and head-down= definite PET [12,55] | NR | NR | NR | Standard sonotubometry+positional change capability | Limited (Japan, specialized centers) |
| Tubomanometry | |||||||
| TMM (R value) | Both | 94.5% at 50 mbar [44] | 93% [61] | 44% [61] | R value classification: good | TMM device (e.g., Tuba®); sealed nasal applicator+EAC probe | Limited (expensive, specialized centers) |
| Continuous R: ICC 0.20-0.83 [60] | |||||||
| Raw EAC pressure: ICC >0.7 [60] | |||||||
| ETS-7 (composite) | Intact | AUC 0.98 [3] | 96% [3] | 96% [3] | ICC 0.87 (ETD); | TMM device+tympanometer (combines 7 items) | Limited (specialized centers) |
| ICC 0.81 (healthy) [3] | |||||||
| ETS-5 (composite) | Perforated | NR | 91% [3] | 86% [3] | ICC 0.82 [3] | TMM device (combines 5 items; no tympanometry required) | Limited (specialized centers) |
| TTAG | |||||||
| TTAG | Both | 76% (Valsalva) [45] | Highly specific for PET (not quantified) | Highly specific for PET (respiratorysynchronous pattern) | NR | JK-05A (RION Co.); dual pressure sensors (EAC+nasopharynx) | Japan mainly; limited global availability |
| 90.0% (Valsalva) [44] | |||||||
| Endoscopic and Imaging-Based Assessment | |||||||
| Video nasopharyngoscopy | Independent of TM | N/A (qualitative visual assessment of 4 dilation phases) | NR (qualitative) | NR (qualitative) | NR | Flexible nasopharyngoscope; video recording system | Widely available |
| CT (sitting/Valsalva) | Independent of TM | Sitting CT: 100% Spe for PET [69] | 79% for PET (sitting CT) [69] | 100% for PET (sitting CT) [69] | N/A (anatomical) | CT scanner; sitting capability for PET; radiation exposure | Standard CT widely available; sitting CT limited |
| Valsalva CT: visualized 94% of obstruction sites [71] | |||||||
| MRI (dynamic) | Independent of TM | N/A (soft tissue/dynamic visualization) | NR | NR | N/A | MRI scanner; real-time turbo-gradient echo sequences; no radiation | Standard MRI widely available; dynamic protocols limited |
| Clinical maneuvers | |||||||
| Valsalva maneuver | Intact | 85%-89% success in healthy adults [38] | NR | NR | Limited; 31% failure rate even in normal ears [76] | None (bedside test); otoscopy or tympanometry for verification | Widely available |
| 78% TM movement detection [45] | |||||||
| Toynbee maneuver | Intact | 56% consistent findings in healthy ears [59] | NR | NR | Limited (effort-dependent) | None (bedside test) | Widely available |
| Politzer method (e.g., MEID) | Intact | ≈88% with automated devices [76] | NR | NR | Superior to Valsalva [76] | Rubber bulb or automated device (e.g., MEID) | Widely available |
| Sniff test | Intact | 30%-46% in healthy ears [45]; valuable for PET/closing failure | NR | NR | NR | None (bedside test) | Widely available |
Detection/opening rates refer to the proportion of healthy ears in which ET opening was successfully detected. “Both” under TM requirement indicates applicability to intact and perforated membranes.
* standard tympanometry does not detect ET opening events; the 29%-40% in the Sensitivity column represents the proportion of ETD ears with abnormal tympanograms.
TM, tympanic membrane; VT, ventilation tube; PEq5, percentage of pressure equilibrated after five swallows; MPD, maximal peak pressure difference; TMM, tubomanometry; ETS, Eustachian Tube Score; TTAG, tubo-tympano-aerodynamic graphy; PSEQ, perfect sequences; EAC, external auditory canal; PET, patulous Eustachian tube dysfunction; ETD, Eustachian tube dysfunction; MEE, middle ear effusion; ICC, intraclass correlation coefficient; AUC, area under the receiver operating characteristic curve; CT, computed tomography; MRI, magnetic resonance imaging; MEID, middle ear inflation device; NR, not reported; N/A, not applicable.

![]() |
![]() |